Search
There were a total of 58 results for your search.
Pirbright partners with ECO Animal Health to combat poultry diseases
The Pirbright Institute has entered into a worldwide exclusive partnership with ECO Animal Health Ltd (ECO), a wholly owned subsidiary of ECO Animal Health Group plc, on two new projects to combat...
Type: News
COVID-19 booster vaccinations help the immune system fight SARS-CoV-2
Pirbright research shows that immunity to SARS-CoV-2 , the virus that causes COVID-19, decreases over time after vaccination, but that booster vaccinations can help restore immunity and help the...
Type: News
Pirbright test detects antibodies that block viruses from causing cell fusion, including SARS-CoV-2
A new test developed by researchers at The Pirbright Institute, in collaboration with the University of Queensland and the University of Oxford, can detect antibodies that prevent cell-to-cell fusion...
Type: Press release
The impact of our research
Our impact Our work has a huge impact both nationally and internationally as we fulfil our mission to be the world's leading innovative centre for preventing and controlling viral diseases of...
Type: Page
Viral Glycoproteins
Our group The group, led by Dr Dalan Bailey, works on a range of RNA viruses including SARS-CoV-2, Nipah virus, respiratory syncytial viruses and the morbilliviruses. Funded by the Medical Research...
Type: Research group
Infectious bronchitis virus shuts down cell stress signals, Pirbright study shows
A new study from scientists at The Pirbright Institute and collaborators at the University of Surrey provides evidence that infectious bronchitis virus (IBV) can regulate the signals involved in the...
Type: News
Pirbright test detects antibodies that block viruses from causing cell fusion, including SARS-CoV-2
A new test developed by researchers at The Pirbright Institute, in collaboration with the University of Queensland and the University of Oxford, can detect antibodies that prevent cell-to-cell fusion...
Type: News
Pirbright reveals new method to study poultry virus (IBV) which could reduce the need to use birds in research
An enzyme called trypsin boosts the growth of infectious bronchitis virus (IBV) strains in lab cell cultures, scientists at The Pirbright Institute have shown. This finding could enable researchers...
Type: News
Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points
One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome chinks in its armour as it evolves, say an international...
Type: News
Celebrating Pirbright student success
Pirbright’s Student Day returned on Wednesday 18 May 2022, for the first time since 2019. This event was a great opportunity for students to share their projects with peers at the Institute. Student...
Type: News